BIO Web Conf.
Volume 22, 2020International Conference “Longevity Interventions 2020” (ICLI 2020)
|Number of page(s)||6|
|Section||Problems of Gerontology and Geriatrics|
|Published online||06 July 2020|
Pathogenetic substantiation of the combined transplantation use of multipotent mesenchymal stromal cells and hepatic stellate cells to restore the liver morphofunctional state after acute toxic hepatitis in the old body
FSBEI HE Ural State Medical University Ministry of Health of the Russian Federation, 620028, Yekaterinburg, Russian Federation
2 SAHI SO “Institute of Medical Cell Technologies”, 620026, Yekaterinburg, Russian Federation
* Corresponding author: email@example.com
The purpose of this study was to study the cotransplantation influence of multipotent mesenchymal stromal (MMSC) and hepatic stellate (HSC) cells on liver regeneration of old laboratory animals in conditions of its toxic damage. Acute toxic hepatitis was caused by single intraperitoneal CC14 injection at a dose of 50 μg/kg. The introduction of MMSC and HSC was carried out at doses of 4 million cl/kg and 9 million cl/kg respectively 1 hour after toxic hepatitis modelling. The morphofunctional liver state of old laboratory mice was evaluated on the 1st, 3rd, 7th day after combined injection of MMSC and HSC in laboratory animals with toxic hepatitis. As a result of the study, it was obtained that MMSC and HSC cotransplantation leads to cellular and intracellular liver regeneration activation in old mice with acute toxic hepatitis. Also, the introduction of these cell types leads to decreased liver mutagenesis, inhibition of programmed cellular hepatocytes death. Thus, the conducted studies indicate the ability of combined MMSC and HSC transplantation to restore the morphofunctional liver state of the old organism under the conditions of its toxic damage.
© The Authors, published by EDP Sciences, 2020
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Statistics data analysis from the Ministry of Health of the Russian Federation, the Department of Monitoring, Analysis and Strategic Development of Health, as well as the World Health Organization for 2018 show an increase in the number of patients with liver pathology . Therapeutic approaches currently used in the treatment of liver failure remain ineffective. This makes finding new methods capable of activating regeneration in a damaged organ relevant.
This study examined the ability of two types of stem cells — hepatic stellate cells (HSC) and multipotent mesenchymal stromal cells (MMSC) to activate liver regeneration in conditions of its toxic damage through the carbon tetrachloride introduction. The choice of these types of stem cells was due to their biological properties. Currently, hepatic stellate cells are seen as contenders for the role of liver stem cell by a number of authors [2, 3]. Their ability to differentiate into hepatocytes, cholangiocytes [3, 4] is shown. Hepatic stellate cells provide synthesis of subendothelial extracellular matrix, which regulates hepatocyte function, produce a wide range of cytokines that increase hepatocytes proliferative activity: hepatocytic growth factor (HGF), stem cell factor (SCF), epimorphine, pleiotrophin. Expressing VCAM-1 and SDF-1a HSC, they provide migration of autologous stem and progenitor cells including MMSC to the liver. MMSC can be compared to the “factory” for biologically active substances production. Thus, synthesized MMSC immunosuppressive factors (TGF-β, IL-10) provide the possibility of allogenic transplantation, significantly reducing the probability of immunological conflicts development [5, 6, 7, 8]. The ability of MMSC through formation of intercellular contacts to induce the production of heat-shock proteins with molecular weight of 70 kD (chaperones) in cells [9, 10, 11] has been proved. This group of proteins supports the conformation of structural and functional proteins. Given these biological relationships between MMSC and HSC, it seems promising to study the effect of combined transplantation of these cell types on liver regeneration in conditions of its damage.
It is known that during aging there is not only a decrease in the stem cells number, a decrease in differentiation ability, but also a decrease in their sensitivity to physiologically active substances [12, 13, 14]. This can determine the characteristics of liver regeneration in the conditions of its toxic damage during aging.
The purpose of this study was to study the MMSC and HSC combined transplantation effect on the liver regeneration of old laboratory animals in the conditions of its toxic damage.
Experiments were performed on 84 white male laboratory mice 16-17 months of age, mass – 25—30 g. MMSC was released from the placenta chorion of 5 female laboratory mice aged 3—4 months, gestation period — 18 days. All experiments, care and management of animals were carried out in accordance with Directive No. 63 dated September 22, 2010 of the Presidency and the Parliament of Europe “On the Protection of Animals Used for Scientific Research” and the Order of the Ministry of Health of the Russian Federation No. 267 of June 19, 2003 “On approval of the rules of laboratory practice”. The research is approved by the local ethical committee of FSBEI HE “Ural State Medical University” Protocol No. 8 dated 20.10.2017.
The mononuclear cell fraction was obtained by sequential mechanical and enzymatic (solution of accutase (Millipore, USA)) processing of placenta tissue. The MMSC immunophenotype is characterized by: CD105+, Sca1+, CD29+, CD45- . Immunophenotyping of MSSC suspension was carried out by flow cytometry method using monoclonal antibodies conjugated with fluorochromes (Becton Dickinson, USA). The MMSC content with immunophenotype positive by CD105, CD29, Sca-1 and negative by CD45 was evaluated in the fraction of transplantable cells on the Beckman Coulter Navios flow cytometer using the Mouse Mesenchymal Stem CellMulti-Color Flow Cytometry Kit (Bio-Techne, USA). The number of viable cells with the CD45-, CD105+, Sca1+, CD29+ phenotype was 93.5%. The HSC release was carried out by collagenase-pronase liver perfusion method followed by cell separation in histogenesis density gradient. The MMSC was cultivated under CO2 conditions — an incubator (Termo Scientific, USA) at a temperature of 370C with 5% carbon dioxide content and 90% humidity. The MMSC of the third passage was used for transplantation to laboratory animals. The HSC introduction was carried out immediately after cells isolation.
The study of isolated cells functional properties was carried out by directed differentiation of the obtained culture in directions characteristic of MMSC – in adipocytic and osteogenic. The HSC identification was performed on the Beckman Coulter Navios flow cytometer by evaluating HSC endogenous retinoid fluorescence. The cell viability was determined by supravital coloration with a solution of tripan blue and amounted to 95 — 97%.
Experimental group animals were intravenously injected with MMSC and HSC at a dose of 4 million cells/kg and 9 million cells/kg respectively, suspended in 0.2 ml 0.9% NaCl solution. The control group animals were injected with 0.9% solution of NaCl — 0.2 ml intravenously. Intravenous injection was performed 1 hour after the simulation of acute toxic hepatitis. Toxic hepatitis was caused by intraperitoneal injection of CCl4 at a dose of 50 μg/kg.
The influence of MMSC and HSC combined transplantation on biochemical parameters of peripheral blood and morphometric liver parameters under physiological conditions and after subtotal resection on the 1st, 3rd, 7th day. The animals were taken out of the experiment with decapitation under mild ethereal anesthesia.
Histological liver cuts 3-5 μm thick stained with hematoxylin-eosin was made. For morphometric data analysis a computer program of image analysis (Biovision, Russia) was used. The following liver morphometric indicators were evaluated: hepatocyte count per 1 mm2, hepatocyte area, hepatocyte nucleus area, hepatocyte cytoplasm area, nuclear – cytoplasmic index (NCI), number of binuclear hepatocytes per 1 mm2, mitotic index (MI), apoptotic index (AI). Verification of apoptosis severity was carried out using the ApopTag® Peroxidase In Situ Oligo Ligation (ISOL) (Millipore, USA) method.
The evaluation of peripheral blood biochemical indicators was performed on the automatic biochemical and immunoenzyme analyzer Chem Well 2910 (Combi). The following biochemical indicators were studied: total protein, albumin, urea, glucose, total bilirubin, aspartataminotransferase (AST), alaninaminotransferase (ALT), alkaline phosphatase (ALP). “Olvex Diagnosticum” (Russia) kits were used in determining biochemical indicators. Determination of fibrinogen concentration was carried out on the hemostasis indicators analyzer APG2-02-P.
Statistical data processing was carried out using the SPSS Statistics software package (version 17.0). The data is represented as arithmetic mean (M) and standard mean error (m). The sample values distribution normality was estimated on the Shapiro—Wilk test. If there is a normal distribution, the differences estimation in group indicators was conducted according to the Student t-criterion, otherwise -the Mann-Whitney U-criterion. The differences were considered statistically significant at p < 0.05.
On the 1st day after MMSC and HSC combined transplantation to old laboratory mice with toxic hepatitis, no reliable differences between experimental and control groups were found.
In the study of morphometric liver indicators of old laboratory animals 3 days after the carbon tetrachloride introduction, animals injected with MMSC and HSC had a decrease in apoptosis levels and increasing number of biconuclear hepatocytes. There was also an increase in the hepatocytes’ nucleus area and a consequent increase in the nuclear cytoplasmic index. In the analysis of the hepatocytes micronuclei number there was a decrease observed compared to the control group (Table 1).
In the morphometric indicators’ analysis of laboratory mice on the 7th day after carbon tetrachloride introduction, increased mitotic index and decreased apoptosis severity were noted in the experimental group. Also, after combined MMSC and HSC injection, an increase in the hepatocyte nuclei area was found, which contributed to the increase of the nuclear cytoplasmic index. In addition, there was an increase in the number of binuclear hepatocytes compared to the control group. Analyzing the number of cytogenetically altered cells, their decrease in comparison with the data of the control group was observed (Table 2).
Thus, it was identified that combined MMSC and HSC transplantation to old laboratory mice under toxic hepatitis conditions leads to activation of cellular and intracellular regeneration. Combined MMSC and HSC introduction led to a decrease in programmed cell death. The decrease in the number of hepatocytes with micronuclei in laboratory animals following the MMSC and HSC introduction indicates the ability of these cells to reduce induced mutagenic activity in the liver under toxic hepatitis conditions.
In the biochemical parameters’ analysis of laboratory mice peripheral blood on the 3rd day after carbon tetrachloride introduction against the background of combined MMSC and HSC transplantation, a decrease in enzymes content characterizing hepatocyte cytolysis: AST, ALT (Table 3) was observed.
In the analysis of the peripheral blood biochemical parameters on the 7th day after the combined MMSC and HSC transplantation against the carbon tetrachloride introduction background, there was a noticeable decrease in the level of AST to values of intact animals, decrease in ALT levels, increase in fibrinogen (Table 4) .
Morphometric liver indicators of old laboratory mice 3 days after CCl4, M±m injection, n = 7
Morphometric liver indicators of laboratory mice on the 7th day after CCl4 injection, M±m, n = 7
Biochemical blood indicators of laboratory mice on the 3rd day after CCl4 injection, M±m, n = 7
Biochemical blood indicators of laboratory mice on the 7th day after CCl4 injection, M±m, n = 7
Conducted studies indicate the ability of combined MMSC and HSC transplantation to activate liver regeneration in the old body under the conditions of its toxic damage. Regeneration activation is achieved through the inclusion of cellular (mitotic activity increase) and intracellular mechanisms (increased number of binuclear hepatocytes, increased nuclear-cytoplasmic index). Regeneration activation may be due to the ability of HSC to produce growth factors, as well as the ability of MMSC to merge – “fusion-effect”. The data obtained also show that introduction of cell species provides reduced mutagenesis and inhibition of programmed cell death. The apoptosis inhibition can be explained by the MMSC ability to induce the production of heat-shock proteins (chaperones) in liver cells through the formation of intercellular contacts. Heat-shock proteins provide stability to structural and functional proteins including reparation enzymes. Thus, the cell gains additional opportunities to repair damage in the DNA molecule structure, resulting in a decrease in programmed cell death and a decrease in the amount of cytogenetically altered cells.
Thus, the conducted studies indicate the ability of combined MMSC and HSC transplantation to restore the morphofunctional liver state of the old organism under the conditions of its toxic damage.
- Russian statistical yearbook. Stat.sb., Rosstat – P 76, 694 (M., 2018) [Google Scholar]
- A. A. Gumerova, A. K. Shafigullina, A. A. Trondin, I. M. Gazizov, D. I. Andreeva, M. S. Kaligin, A. A. Rizvanov, A. P. Kiasov, Cell transplantology and tissue engineering, 6 (4), 72-81 (2011) [Google Scholar]
- C. Kordes, I. Sawitza, S. Gotze, D. Herebian, Journal of Clinical Investigation, 124 (12), 5503-5515 (2014) [CrossRef] [PubMed] [Google Scholar]
- C. Yin, K. J. Evason, K. Asahina, D. Y. Stainier, Journal of Clinical Investigation, 123 (5), 1902-1910 (2013) [CrossRef] [Google Scholar]
- J. Jung, J. Choi, Y. Lee [et al.], Stem cells, 31, 1584-1596 (2013) [CrossRef] [PubMed] [Google Scholar]
- I. Y. Maklakova, D. Y. Bulletin of Experimental Biology and Medicine, 163 (1), 61-64 (2017) [CrossRef] [Google Scholar]
- D. J. Prockop, J. Y. Oh, Mol. Ther., 20 (1), 14-20 (2012) [CrossRef] [PubMed] [Google Scholar]
- A. A. Brilliant, Yu. M. Brilliant, S. V. Sazonov, European Journal of Cancer, 49 (S2), 216 (2013) [Google Scholar]
- R. M. Samsonraj, M. Raghunath, V. Nurcombe, [et al.], Stem Cells Transl. Med., 6 (12), 2173 (2017) [CrossRef] [PubMed] [Google Scholar]
- S. F. H. de Witte, M. Franquesa, C. C. Baan, M. J. Hoogduijn, Frontiers in Immunology, 6, 648 (2016) [PubMed] [Google Scholar]
- N. Pilat, L. Unger, G. A. Berlakovich, Hindawi Publishing Corporation International Journal of Hepatology, 7, (2013) Article ID 310612; http://dx.doi.org/10.1155/2013/310612. [Google Scholar]
- N. A. Timchenko, Trends in Endocrinology & Metabolism, 4 (20), 171-176 (2009) [CrossRef] [Google Scholar]
- R. A. B. Nucci, A. C. S. Teodoro, E. F. Gama, Morphol. Sci, 33 (4), 179-182 (2016) [CrossRef] [Google Scholar]
- G. K. Michalopoulos, J. Cell Physiol, 213 (2), 286-300 (2007) [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.